Shukra Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Shukra Pharmaceuticals has a total shareholder equity of ₹542.9M and total debt of ₹27.2M, which brings its debt-to-equity ratio to 5%. Its total assets and total liabilities are ₹806.7M and ₹263.8M respectively. Shukra Pharmaceuticals's EBIT is ₹161.7M making its interest coverage ratio -62.3. It has cash and short-term investments of ₹180.3M.
Key information
5.0%
Debt to equity ratio
₹27.25m
Debt
| Interest coverage ratio | -62.3x |
| Cash | ₹180.34m |
| Equity | ₹542.85m |
| Total liabilities | ₹263.82m |
| Total assets | ₹806.67m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524632's short term assets (₹593.2M) exceed its short term liabilities (₹206.7M).
Long Term Liabilities: 524632's short term assets (₹593.2M) exceed its long term liabilities (₹57.1M).
Debt to Equity History and Analysis
Debt Level: 524632 has more cash than its total debt.
Reducing Debt: 524632's debt to equity ratio has reduced from 44.8% to 5% over the past 5 years.
Debt Coverage: 524632's debt is well covered by operating cash flow (503.8%).
Interest Coverage: 524632 earns more interest than it pays, so coverage of interest payments is not a concern.